Last $45.79 USD
Change Today +0.43 / 0.95%
Volume 6.9M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 8:04 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Pension Plan for glaxosmithkline plc-spon adr (GSK)

Shares for Stock Options
-- Million
Common Shares for Exercise
For the fiscal year 2013 in British Pounds
Projected Benefit Obligation280.00
Accumulative Benefit Obligation572.00
Total Pension Assets15,225.00
Def. Benefit Service Cost280.00
Def. Benefit Plan Interest Cost572.00
Def. Benefit Plan Return On Assets-526.00
Def. Benefit Plan Other Cost-13.00
Def. Benefit Plan Total Cost313.00
Def. Contribution Plan Cost32.00
Total Pension Expense345.00
Exp. Ret. on Pension Assets--
Discount Rate on Obligation4.50
Assumed Comp. Growth Rate--
Other Post-Retire Benefits Exp.-175.00
Other Benefits Obligation1,246.00

Stock Options for glaxosmithkline plc-spon adr (GSK)

Outstanding at Beginning of Year77.79
Issued During the Year1.09
Exercised During the Year32.70
Canceled During the Year3.51
Outstanding at the End of Year42.67
W/Avg. Exercise Price of Options Granted12.47
W/Avg. Exercise Price of Options Outstanding--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:US $45.79 USD +0.43

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $148.59 USD +3.54
AbbVie Inc $60.29 USD +0.77
Amgen Inc $147.26 USD +0.01
Bayer AG €105.85 EUR -0.81
Novo Nordisk A/S kr267.10 DKK -2.40
View Industry Companies
 

Industry Analysis

GSK

Industry Average

Valuation GSK Industry Range
Price/Earnings 13.6x
Price/Sales 2.6x
Price/Book 10.4x
Price/Cash Flow 13.5x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.